• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

毛细血管前性肺动脉高压患者血浆血管性血友病因子唾液酸含量降低

Decreased sialic acid content of plasma von Willebrand factor in precapillary pulmonary hypertension.

作者信息

Lopes A A, Ferraz de Souza B, Maeda N Y

机构信息

Heart Institute, School of Medicine of the University of São Paulo, Brazil.

出版信息

Thromb Haemost. 2000 May;83(5):683-7.

PMID:10823262
Abstract

In pulmonary hypertension, defective von Willebrand factor protein (vWF) lacking large multimers is present in circulation. This is associated with evidence of chronic endogenous platelet activation. Since asialo vWF has been shown to promote platelet activation and aggregation, we decided to investigate possible changes in the sialic acid content of plasma vWF in patients with precapillary pulmonary hypertension. vWF-associated sialic acid was measured indirectly as a wheat germ agglutinin-reactive substance (WGA-RS, Western blotting), and directly, as a thiobarbituric acid-reactive substance (TBA-RS, spectrophotometric reading). In the sixteen patients we studied (ages 8-45 yr), circulating vWF concentration was 2.18 times normal (p <0.001). However, patient vWF subunit contained 19% (WGA-RS) to 24% (TBA-RS) less sialic acid than the normal protein (p <0.05 for both determinations). In five patients, vWF-associated sialic acid was below 50% normal. We conclude that circulating vWF is hyposialylated in precapillary pulmonary hypertension and speculate that this might influence its interaction with platelets in vivo in these patients.

摘要

在肺动脉高压患者中,循环系统中存在缺乏大分子量多聚体的有缺陷的血管性血友病因子蛋白(vWF)。这与慢性内源性血小板激活的证据相关。由于去唾液酸vWF已被证明可促进血小板激活和聚集,我们决定研究毛细血管前肺动脉高压患者血浆vWF唾液酸含量的可能变化。vWF相关唾液酸通过间接作为麦胚凝集素反应性物质(WGA-RS,蛋白质印迹法)和直接作为硫代巴比妥酸反应性物质(TBA-RS,分光光度读数)来测量。在我们研究的16名患者(年龄8 - 45岁)中,循环vWF浓度是正常水平的2.18倍(p <0.001)。然而,患者vWF亚基的唾液酸含量比正常蛋白少19%(WGA-RS)至24%(TBA-RS)(两种测定方法的p均<0.05)。在5名患者中,vWF相关唾液酸低于正常水平的50%。我们得出结论,毛细血管前肺动脉高压患者循环中的vWF唾液酸含量减少,并推测这可能会影响其在这些患者体内与血小板的相互作用。

相似文献

1
Decreased sialic acid content of plasma von Willebrand factor in precapillary pulmonary hypertension.毛细血管前性肺动脉高压患者血浆血管性血友病因子唾液酸含量降低
Thromb Haemost. 2000 May;83(5):683-7.
2
Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.1型和2型先天性血管性血友病患者血管性血友病因子参数对去氨加压素的反应:诊断和治疗意义
Semin Thromb Hemost. 2002 Apr;28(2):111-32. doi: 10.1055/s-2002-27814.
3
Abnormal degradation of von Willebrand factor main subunit in pulmonary hypertension.肺动脉高压中血管性血友病因子主要亚基的异常降解
Eur Respir J. 1995 Apr;8(4):530-6.
4
Characterization of von Willebrand factor in primary pulmonary hypertension.原发性肺动脉高压中血管性血友病因子的特征
Heart Vessels. 1999;14(5):246-52. doi: 10.1007/BF01747854.
5
Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.1型/2E型(2A亚型IIE)血管性血友病、1型维琴察型血管性血友病以及由血管性血友病因子基因的D3、D4、B1 - B3和C1 - C2结构域突变引起的轻型1型血管性血友病的实验室诊断。血管性血友病因子多聚体及血管性血友病因子前肽/抗原比值的作用。
Acta Haematol. 2009;121(2-3):128-38. doi: 10.1159/000214853. Epub 2009 Jun 8.
6
Inverse relation between plasma concentration of von Willebrand factor and CrEDTA clearance in systemic sclerosis.系统性硬化症中血管性血友病因子血浆浓度与CrEDTA清除率之间的负相关关系。
J Rheumatol. 1994 Apr;21(4):639-42.
7
Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.基于酶联免疫吸附测定法测量血管性血友病因子与糖蛋白Ibaα重组片段的结合:2B型血管性血友病患者的检测性能
Br J Haematol. 2006 Jun;133(6):655-63. doi: 10.1111/j.1365-2141.2006.06095.x.
8
O-linked glycosylation and functional incompatibility of porcine von Willebrand factor for human platelet GPIb receptors.猪血管性血友病因子与人类血小板糖蛋白 Ib 受体的 O 连接糖基化及功能不相容性
Xenotransplantation. 2005 Jan;12(1):30-7. doi: 10.1111/j.1399-3089.2004.00187.x.
9
Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease.血小板血管性血友病因子测定并不能改善疑似1型血管性血友病患者的诊断。
Haemophilia. 2009 Jan;15(1):131-4. doi: 10.1111/j.1365-2516.2008.01904.x. Epub 2008 Oct 23.
10
Hypoxia and altered platelet behavior influence von Willebrand factor multimeric composition in secondary pulmonary hypertension.
Clin Appl Thromb Hemost. 2003 Jul;9(3):251-8. doi: 10.1177/107602960300900311.

引用本文的文献

1
The Glycobiology of Pulmonary Arterial Hypertension.肺动脉高压的糖生物学
Metabolites. 2022 Apr 1;12(4):316. doi: 10.3390/metabo12040316.
2
Severe COVID-19 is associated with endothelial activation and abnormal glycosylation of von Willebrand factor in patients undergoing hemodialysis.在接受血液透析的患者中,重症新型冠状病毒肺炎与内皮细胞活化及血管性血友病因子的异常糖基化有关。
Res Pract Thromb Haemost. 2021 Sep 12;5(6):e12582. doi: 10.1002/rth2.12582. eCollection 2021 Aug.
3
Desialylation of O-glycans activates von Willebrand factor by destabilizing its autoinhibitory module.
糖链去唾液酸化通过破坏其自身抑制模块使血管性血友病因子(von Willebrand factor,vWF)激活。
J Thromb Haemost. 2022 Jan;20(1):196-207. doi: 10.1111/jth.15528. Epub 2021 Sep 26.
4
Sialylation on O-linked glycans protects von Willebrand factor from macrophage galactose lectin-mediated clearance.O-连接糖蛋白上的唾液酸化可保护血管性血友病因子免受巨噬细胞半乳糖凝集素介导的清除。
Haematologica. 2022 Mar 1;107(3):668-679. doi: 10.3324/haematol.2020.274720.
5
Association of Single Nucleotide Polymorphisms in the ST3GAL4 Gene with VWF Antigen and Factor VIII Activity.ST3GAL4基因单核苷酸多态性与血管性血友病因子抗原及凝血因子VIII活性的关联
PLoS One. 2016 Sep 1;11(9):e0160757. doi: 10.1371/journal.pone.0160757. eCollection 2016.
6
Congenital heart disease and pulmonary arterial hypertension in South America (2013 Grover Conference series).南美洲的先天性心脏病与肺动脉高压(2013年格罗弗会议系列)
Pulm Circ. 2014 Sep;4(3):370-7. doi: 10.1086/676747.